BrainCool AB (publ) - BrainCool provides an update on Medicare Coverage of Innovative Technology (MCIT) rule
Medicare Coverage of Innovative Technology (MCIT) rule is to provide a coverage pathway for medicare beneficiaries to access FDA-cleared or approved breakthrough devices during an initial four-year period after FDA clearance or approval. Following a previously announced delay in the implementation of the final rule establishing the MCIT pathway, the Centers for Medicare & Medicaid Services (CMS) has now issued a proposal to repeal the final rule prior to implementation on December 15, 2021. CMS states that it believes there are other ways to achieve the goal of providing innovation